Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Acq. announced
Director departure
Letter to company
Asset disposition
Appointed director

NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/10/2016 8-K/A Form 8-K/A - Current report [Amend]
10/09/2015 8-K/A Financial Statements and Exhibits
Docs: "Term Loan Agreement, by and among Navidea Biopharmaceuticals, Inc., as borrower, Macrophage Therapeutics, Inc. as guarantor, and Capital Royalty Partners II L.P., Capital Royalty Partners II – Parallel Fund “A” L.P. and Parallel Investment Opportunities Partners II L.P., as lenders (filed herewith)"
05/21/2015 8-K/A Quarterly results
Docs: "Term Loan Agreement, by and among Navidea Biopharmaceuticals, Inc., as borrower, Macrophage Therapeutics, Inc. as guarantor, and Capital Royalty Partners II L.P., Capital Royalty Partners II – Parallel Fund “A” L.P. and Parallel Investment Opportunities Partners II L.P., as lenders (filed herewith)"
06/28/2013 8-K/A Form 8-K/A - Current report [Amend]
11/13/2012 8-K/A Other Events, Financial Statements and Exhibits
04/11/2012 8-K/A Form 8-K/A - Current report [Amend]
08/17/2011 8-K/A Form 8-K/A - Current report [Amend]
07/19/2011 8-K/A Form 8-K/A - Current report [Amend]
06/09/2011 8-K/A Form 8-K/A - Current report [Amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy